Could a malaria drug boost chemo for pancreatic cancer?
NCT ID NCT04911816
First seen Apr 28, 2026 · Last updated May 01, 2026 · Updated 1 time
Summary
This study tests whether adding hydroxychloroquine (a malaria drug) to standard chemotherapy before and after surgery can help treat pancreatic cancer that can be removed. About 40 adults with resectable pancreatic cancer will receive the combination, then undergo surgery. Researchers will check safety, the highest safe dose, and how well the tumor responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOCARCINOMA OF THE PANCREAS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
West Virginia University Cancer Institute Mary Babb Randolph Cancer Center
RECRUITINGMorgantown, West Virginia, 26506, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.